Senator Grassley has written to NAMI director Michael J. Fitzpatrick (pictured on right) requesting information about psychiatric pharmaceutical industry funding of NAMI state chapters.
NAMI’s executive director Michael J. Fitzpatrck has been asked to respond by Sen. Grassley about psychiatric drug funding of NAMI State Chapters.
1 May 2010
NAMI-Gate Goes Local
NAMI State Chapters Investigated for Psychiatric Drug Company Funding
In 2009, Sen. Grassley determined that more than half of national NAMI’s income secretly came from psychiatric drug corporations.
In 2010, Sen. Grassley is asking for each NAMI State Chapter – each their own nonprofit corporation – to disclose their own funding from drug companies. NAMI California gets the most with $632,000.
Senator Grassley has written his 26 April letter to Michael J. Fitzpatrick, Executive Director of NAMI (shown here upper right) and Stephen H. Feinstein, M.D., NAMI President.
As of today, two NAMI state chapters still have not provided Sen. Grassley with the information he has requested: Arizona and Hawaii.
Here’s your gateway to information about the US Senate’s investigation of psychiatric drug company money of NAMI’s State Chapters:
- 28 April 2010 – Wall St. Journal blog briefly sums up story about Sen. Grassley investigating NAMI State Chapters.
- 28 April 2010 – The Chronicle of Philanthropy also covers the story.
- You may download a PDF of Sen. Grassley’s letter to NAMI, demanding information about psychiatric drug company funding of NAMI State Chapters.
- Vera Hassner Sharav analyzes the latest info about NAMI drug company money.
- Here’s a folder of information about investigations of NAMI, especially psychiatric drug company funding.
- More info about NAMI on the MindFreedom web site.
- NAMI’s new web page at request of Sen. Grassley, with reports about their psychiatric drug company funding.
- NAMI’s web site.
Document Actions